19-6897454-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001974.5(ADGRE1):c.421G>A(p.Val141Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000085 in 1,599,420 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001974.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ADGRE1 | NM_001974.5 | c.421G>A | p.Val141Ile | missense_variant | 5/21 | ENST00000312053.9 | NP_001965.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ADGRE1 | ENST00000312053.9 | c.421G>A | p.Val141Ile | missense_variant | 5/21 | 1 | NM_001974.5 | ENSP00000311545.3 |
Frequencies
GnomAD3 genomes AF: 0.0000855 AC: 13AN: 152078Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.000113 AC: 27AN: 237952Hom.: 0 AF XY: 0.000117 AC XY: 15AN XY: 128624
GnomAD4 exome AF: 0.0000850 AC: 123AN: 1447224Hom.: 0 Cov.: 33 AF XY: 0.0000904 AC XY: 65AN XY: 719226
GnomAD4 genome AF: 0.0000854 AC: 13AN: 152196Hom.: 0 Cov.: 31 AF XY: 0.0000807 AC XY: 6AN XY: 74392
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 18, 2021 | The c.421G>A (p.V141I) alteration is located in exon 5 (coding exon 5) of the ADGRE1 gene. This alteration results from a G to A substitution at nucleotide position 421, causing the valine (V) at amino acid position 141 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at